Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development

Class:IdLiteratureReference:9665800
_displayNameDeletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development
_timestamp2019-11-01 01:32:01
author[Person:9665805] d'Oiron, Roseline
[Person:9665816] Lavergne, Jean-Maurice
[Person:9661624] Lavend'homme, Renaud
[Person:9665797] Benhida, Abdellah
[Person:9665812] Bordet, Jean-Claude
[Person:9665803] Negrier, Claude
[Person:9661586] Peerlinck, Kathelijne
[Person:8936464] Vermylen, Jos
[Person:9661585] Saint-Remy, Jean-Marie
[Person:9661691] Jacquemin, Marc
created[InstanceEdit:9665826] Shamovsky, Veronica, 2019-11-01
journalBlood
pages155-7
pubMedIdentifier12969981
titleDeletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development
volume103
year2004
(literatureReference)[EntityWithAccessionedSequence:9665793] F8 A2220del [extracellular region] [Homo sapiens]
[CandidateSet:9665831] FVIII C1, C2 domain variants [extracellular region] [Homo sapiens]
[Summation:9665830] Coagulation factor VIII (FVIII) encoded by the F8 gene is sy...
[FailedReaction:9665809] F8 variant does not bind von Willebrand factor [Homo sapiens]
[Pathway:9672393] Defective F8 binding to von Willebrand factor [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Deletion of alanine 2201 in the FVIII C2 domain results in mild hemophilia A by impairing FVIII binding to VWF and phospholipids and destroys a major FVIII antigenic determinant involved in inhibitor development (9665800)